tradingkey.logo

BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat

ReutersFeb 27, 2025 7:02 PM

Shares of drugmaker Catalyst Pharmaceuticals CPRX.O rise 7.9% to $22.21

Company late on Wednesday forecast 2025 revenue in the range of $545 million to $565 millionn, analysts on average expect revenue to be $556.9 million, as per data compiled by LSEG

CPRX posted fourth-quarter revenue of $141.8 million, beating analysts' estimate of $134.2 million

Reported adj quarterly profit of 70 cents/share vs analysts' estimate of 34 cents/share

Stock has risen 41.1% in the past 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI